This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Menten AI, Inc.


Backed by top VCs including Uncork Capital, Khosla Ventures, and Y-Combinator, Menten AI is building generative AI to design next-generation macrocyclic therapeutics for challenging drug targets. It's the first platform capable of designing potent and membrane-permeable macrocycles in a matter of days. The team has demonstrated the robustness of their platform for complex drug targets including protein-protein interfaces and intracellular targets and has partnerships with top-10 pharma to accelerate their preclinical drug discovery efforts.